Lundbeck
HLUN-B.CO
#2807
Rank
S$7.79 B
Marketcap
S$7.85
Share price
0.87%
Change (1 day)
7.59%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): S$0.80

According to Lundbeck's latest financial reports the company's current EPS (TTM) is S$0.77. an increase over its 2024 EPS that were of S$0.56.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025S$0.6414.5%
2024S$0.5629.29%
2023S$0.4323.09%
2022S$0.3537.26%
2021S$0.26-84.61%
2020S$1.66-24.61%
2019S$2.21-42.06%
2018S$3.8140.7%
2017S$2.71146.26%
2016S$1.10-120.48%
2015S-$5.373231.32%
2014S-$0.16-115.78%
2013S$1.02-23.36%
2012S$1.33-48.01%
2011S$2.56-9.68%
2010S$2.8413.72%
2009S$2.5024.32%
2008S$2.01-6.05%
2007S$2.1481.77%
2006S$1.18-16.76%
2005S$1.41-17.58%
2004S$1.71